Health economic burden of obesity - an international perspective

Obesity Epidemiology: From Aetiology to Public Health

Volumn , Issue , 2010, Pages

  Müller Riemenschneider, Falk ^a   Reinhold, Thomas ^a   von Schulzendorff, Adrian ^a   Willich, Stefan N ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Economic burden; Health economics; Obesity; Overweight; Public health

Indexed keywords

EID: 84921258674     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1093/acprof:oso/9780199571512.003.0006     Document Type: Chapter

References (61)

1. Popkin BM, Kim S, Rusev ER, Du S, Zizza C (2006). Measuring the full economic costs of diet, physical activity and obesity-related chronic diseases. Obes Rev, 7(3), 271-293.
2. Ezzati M, Lopez AD, Rodgers A, Vander HS, Murray CJ (2002). Selected major risk factors and global and regional burden of disease. Lancet, 360(9343), 1347-1360.
3. Haslam DW and James WP (2005). Obesity. Lancet, 366(9492), 1197-1209.
4. International Association for the Study of Obesity (2006). Global Obesity Prevalence in Adults. .
5. Fry J and Finley W (2005). The prevalence and costs of obesity in the EU. Proc Nutr Soc, 64(3), 359-362.
6. Martinez JA, Kearney JM, Kafatos A, Paquet S, Martinez-Gonzalez MA (1999). Variables independently associated with self-reported obesity in the European Union. Public Health Nutr, 2(1A), 125-133.
7. Organization for Economic Cooperation and Development (2007). Health at a glance 2007: OECD indicators.
8. The Oxford Health Alliance (2006). Chronic diseases: An economic perspective.
9. Federal Statistical Office (2009). Federal Health Monitoring Information Services. Federal Statistical Office Germany, Wiesbaden [2009 [cited 2006 Sept. 1]; . Accessed August 2009.
10. Organization for Economic Cooperation and Development (2005). Health at a glance 2005: OECD indicators.
11. Gold M, Siegel J, Russell L, Weinstein M (1996). Cost-effectiveness in health and medicine. New York, Oxford University Press.
12. Koopmanschap MA, Touw KC, Rutten FF (2001). Analysis of costs and cost-effectiveness in multinational trials. Health Policy, 58(2), 175-186.
13. Kaplan GA and Keil JE (1993). Socio-economic factors and cardiovascular disease: a review of the literature. Circulation, 88(4 Pt 1), 1973-1998.
14. Drummond MF and Pang F (2001). Transferability of economic evaluation results. In: Drummond MF, McGuire A, eds. Economic evaluation in health care: Merging theory with practice. Oxford, Oxford University Press.
15. Pang F (2002). Design, analysis and presentation of multinational economic studies: the need for guidance. Pharmacoeconomics, 20(2), 75-90.
16. Branca F, Nikogosian H, Lobstein T (2007). The challenge of obesity in the WHO European Region and the strategies for response: summary.
17. Muller-Riemenschneider F, Reinhold T, Berghofer A, Willich SN (2008). Health-economic burden of obesity in Europe. Eur J Epidemiol, 23(8), 499-509.
18. Odegaard K, Borg S, Persson U, Svensson M (2008). The Swedish cost burden of overweight and obesity-evaluated with the PAR approach and a statistical modelling approach. Int J Pediatr Obes, 3 Suppl 1, 51-57.
19. Levy E, Levy P, Le PC, Basdevant A (1995). The economic cost of obesity: the French situation. Int J Obes Relat Metab Disord, 19(11), 788-792.
20. Knai C, Suhrcke M, Lobstein T (2007). Obesity in Eastern Europe: an overview of its health and economic implications. Econ Hum Biol, 5(3), 392-408.
21. Report by the Comptroller and Auditor General. Tackling Obesity in England. 15 February 2001. HC 220 Session 2000-2001.
22. U.S. Department of Health and Human Services (2001). The Surgeon General's call to action to prevent and decrease overweight and obesity.
23. Wolf AM and Colditz GA (1998). Current estimates of the economic cost of obesity in the United States. Obes Res, 6(2), 97-106.
24. Thorpe KE, Florence CS, Howard DH, Joski P (2004). The impact of obesity on rising medical spending. Health Aff (Millwood), Suppl Web Exclusives:W4-W6.
25. Birmingham CL, Muller JL, Palepu A, Spinelli JJ, Anis AH (1999). The cost of obesity in Canada. CMAJ, 160(4), 483-488.
26. Katzmarzyk PT and Janssen I (2004). The economic costs associated with physical inactivity and obesity in Canada: an update. Can J Appl Physiol, 29(1), 90-115.
27. Reinhold T, von Schultzendorff A, Müller-Riemenschneider F, Willich S (2009). The Health Economic Consequences of Overweight and Obesity in Asia-Pacific (to be published).
28. Zhao W, Zhai Y, Hu J, et al. (2008). Economic burden of obesity-related chronic diseases in Mainland China. Obes Rev, 9 Suppl 1, 62-67.
29. Finkelstein EA, Ruhm CJ, Kosa KM (2005). Economic causes and consequences of obesity. Annu Rev Public Health, 26, 239-257.
30. Allison DB, Zannolli R, Narayan KM (1999). The direct health care costs of obesity in the United States. Am J Public Health, 89(8), 1194-1199.
31. Gorsky RD, Pamuk E, Williamson DF, Shaffer PA, Koplan JP (1996). The 25-year health care costs of women who remain overweight after 40 years of age. Am J Prev Med, 12(5), 388-394.
32. Thompson D, Edelsberg J, Colditz GA, Bird AP, Oster G (1999). Lifetime health and economic consequences of obesity. Arch Intern Med, 159(18), 2177-2183.
33. Daviglus ML, Liu K, Yan LL, et al. (2004). Relation of body mass index in young adulthood and middle age to Medicare expenditures in older age. JAMA, 292(22), 2743-2749.
34. Yang Z and Hall AG (2008). The financial burden of overweight and obesity among elderly Americans: the dynamics of weight, longevity, and health care cost. Health Serv Res, 43(3), 849-868.
35. Finkelstein EA, Trogdon JG, Brown DS, Allaire BT, Dellea PS, Kamal-Bahl SJ (2008). The lifetime medical cost burden of overweight and obesity: implications for obesity prevention. Obesity (Silver Spring), 16(8), 1843-1848.
36. van Baal PH, Polder JJ, de Wit GA, et al. (2008). Lifetime medical costs of obesity: prevention no cure for increasing health expenditure. PLoS Med, 5(2), e29.
37. Segal L, Carter R, Zimmet P (1994). The cost of obesity: the Australian perspective. Pharmacoeconomics, 5(Suppl 1), 45-52.
38. Detournay B, Fagnani F, Phillippo M, et al. (2000). Obesity morbidity and health care costs in France: an analysis of the 1991-1992 Medical Care Household Survey. Int J Obes Relat Metab Disord, 24(2), 151-155.
39. Sander B and Bergemann R (2003). Economic burden of obesity and its complications in Germany. Eur J Health Econ, 4(4), 248-253.
40. Vellinga A, O'Donovan D, De La HD (2008). Length of stay and associated costs of obesity related hospital admissions in Ireland. BMC Health Serv Res, 8, 88.
41. Seidell JC (1995). The impact of obesity on health status: some implications for health care costs. Int J Obes Relat Metab Disord, 19 Suppl 6, S13-S16.
42. Swinburn B, Ashton T, Gillespie J, et al. (1997). Health care costs of obesity in New Zealand. Int J Obes Relat Metab Disord, 21(10), 891-896.
43. Borg S, Persson U, Odegaard K, Berglund G, Nilsson JA, Nilsson PM (2005). Obesity, survival, and hospital costs-findings from a screening project in Sweden. Value Health, 8(5), 562-571.
44. Narbro K, Jonsson E, Larsson B, Waaler H, Wedel H, Sjostrom L (1996). Economic consequences of sickleave and early retirement in obese Swedish women. Int J Obes Relat Metab Disord, 20(10), 895-903.
45. Schmid A, Schneider H, Golay A, Keller U (2005). Economic burden of obesity and its comorbidities in Switzerland. Soz Praventivmed, 50(2), 87-94.
46. Fu T, Wen T, Yeh P, Chang H (2008). Costs of metabolic syndrome-related diseases induced by obesity in Taiwan. Obes Rev, 9 Suppl 1, 68-73.
47. Allender S and Rayner M (2007). The burden of overweight and obesity-related ill health in the UK. Obes Rev, 8(5), 467-473.
48. Narbro K, Agren G, Jonsson E, Naslund I, Sjostrom L, Peltonen M (2002). Pharmaceutical costs in obese individuals: comparison with a randomly selected population sample and long-term changes after conventional and surgical treatment: the SOS intervention study. Arch Intern Med, 162(18), 2061-2069.
49. von Lengerke T, Reitmeir P, John J (2006). [Direct medical costs of (severe) obesity: a bottom-up assessment of over- vs. normal-weight adults in the KORA-study region (Augsburg, Germany)]. Gesundheitswesen, 68(2), 110-115.
50. Esposti ED, Sturani A, Valpiani G, et al. (2006). The relationship between body weight and drug costs: An Italian population-based study. Clin Ther, 28(9), 1472-1481.
51. Janssen I, Lam M, Katzmarzyk PT (2009). Influence of overweight and obesity on physician costs in adolescents and adults in Ontario, Canada. Obes Rev, 10(1), 51-57.
52. Hu HY, Chou YJ, Chou P, Lee CH, Lee MC, Huang N (2008). Association between obesity and medical care expenditure among Taiwanese adults. Asia Pac J Clin Nutr, 17(3), 492-504.
53. Kuriyama S, Tsuji I, Ohkubo T, et al. (2002). Medical care expenditure associated with body mass index in Japan: the Ohsaki Study. Int J Obes Relat Metab Disord, 26(8), 1069-1074.
54. Kuriyama S, Hozawa A, Ohmori K, et al. (2004). Joint impact of health risks on health care charges: 7-year followup of National Health Insurance beneficiaries in Japan (the Ohsaki Study). Prev Med, 39(6), 1194-1199.
55. Nakamura K, Okamura T, Kanda H, Hayakawa T, Okayama A, Ueshima H (2007). Medical costs of obese Japanese: a 10-year follow-up study of National Health Insurance in Shiga, Japan. Eur J Public Health, 17(5), 424-429.
56. Ohmori-Matsuda K, Kuriyama S, Hozawa A, Nakaya N, Shimazu T, Tsuji I (2007). The joint impact of cardiovascular risk factors upon medical costs. Prev Med, 44(4), 349-355.
57. Brown WJ, Hockey R, Dobson A (2008). Physical activity, Body Mass Index and health care costs in mid-age Australian women. Aust N Z J Public Health, 32(2), 150-155.
58. Raebel MA, Malone DC, Conner DA, Xu S, Porter JA, Lanty FA (2004). Health services use and health care costs of obese and nonobese individuals. Arch Intern Med, 164(19), 2135-2140.
59. Wee CC, Phillips RS, Legedza AT, et al. (2005). Health care expenditures associated with overweight and obesity among US adults: importance of age and race. Am J Public Health, 95(1), 159-165.
60. Thompson D, Brown JB, Nichols GA, Elmer PJ, Oster G (2001). Body mass index and future healthcare costs: a retrospective cohort study. Obes Res, 9(3), 210-218.
61. Andreyeva T, Sturm R, Ringel JS (2004). Moderate and severe obesity have large differences in health care costs. Obes Res, 12(12), 1936-1943.